Organon & Co. (OGN) Financial Statements (2024 and earlier)

Company Profile

Business Address 30 HUDSON STREET
JERSEY CITY, NJ 07302
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

9/30/2023
MRQ
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments706737
Cash and cash equivalents706737
Receivables1,4751,382
Inventory, net of allowances, customer advances and progress billings1,003915
Inventory1,003915
Other current assets747726
Total current assets:3,9313,760
Noncurrent Assets
Inventory, Noncurrent14876
Operating lease, right-of-use asset 215230
Property, plant and equipment1,018973
Intangible assets, net (including goodwill)5,2525,254
Goodwill4,6034,603
Intangible assets, net (excluding goodwill)649651
Other undisclosed noncurrent assets391388
Total noncurrent assets:7,0246,921
TOTAL ASSETS:10,95510,681
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,3171,568
Taxes payable185
Employee-related liabilities1
Accounts payable1,1321,382
Accrued liabilities185 
Debt89
Other undisclosed current liabilities1,1871,020
Total current liabilities:2,5122,597
Noncurrent Liabilities
Long-term debt and lease obligation8,9059,125
Long-term debt, excluding current maturities8,9059,125
Liabilities, other than long-term debt430467
Deferred income tax liabilities194
Other liabilities411463
Total noncurrent liabilities:9,3359,592
Total liabilities:11,84712,189
Equity
Equity, attributable to parent(892)(1,508)
Common stock33
Accumulated other comprehensive loss(564)(513)
Accumulated deficit(331)(998)
Total equity:(892)(1,508)
TOTAL LIABILITIES AND EQUITY:10,95510,681

Income Statement (P&L) ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
Revenues6,1746,304
Cost of revenue
(Cost of Goods and Services Sold)
(2,294)(2,382)
Gross profit:3,8803,922
Operating expenses(2,310)(2,114)
Operating income:1,5701,808
Nonoperating income (expense)
(loss, Foreign Currency Transaction, before Tax)
(11) 
Interest and debt expense(422)(258)
Income from continuing operations before equity method investments, income taxes:1,1371,550
Other undisclosed loss from continuing operations before income taxes(15)(21)
Income from continuing operations before income taxes:1,1221,529
Income tax expense(205)(178)
Income from continuing operations:9171,351
Income before gain (loss) on sale of properties:1,351
Net income available to common stockholders, diluted:9171,351

Comprehensive Income ($ in millions)

9/30/2023
TTM
12/31/2022
12/31/2021
Net income:9171,351
Other comprehensive income (loss)(51)98
Comprehensive income, net of tax, attributable to parent:8661,449

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: